
hemeoncalgorithms
.pdf
|
|
R.H. Sills |
Useful normal laboratory values |
Useful normal laboratory values
106
Normal blood count values from birth to 18 years
Age |
Hb |
RBC |
HCT |
MCV |
WBC |
Neutrophils |
Lymphocytes |
Monocytes |
Eosinophils |
Basophils |
Platelets |
|
g/dl |
×1012/I |
|
fl |
×109/I |
×109/I |
×109/I |
× 109/I |
×109/I |
×109/I |
×109/I |
Birth (term infants) |
14.9–23.7 |
3.7–6.5 |
0.47–0.75 |
100–125 |
10.0–26.0 |
2.7–14.4 |
2.0–17.3 |
0.00–1.9 |
0.00–0.85 |
0.00–0.10 |
150–450 |
2 weeks |
13.4–19.8 |
3.9–5.9 |
0.41–0.65 |
088–110 |
16.0–21.0 |
1.5–15.4 |
2.8–19.1 |
0.10–1.7 |
0.00–0.85 |
0.00–0.10 |
170–500 |
2 months |
19.4–13.0 |
3.1–4.3 |
0.28–0.42 |
084–098 |
15.0–15.0 |
0.7–14.8 |
3.3–10.3 |
0.40–1.2 |
0.05–0.90 |
0.02–0.13 |
210–650 |
6 months |
10.0–13.0 |
3.8–4.9 |
0.30–0.38 |
073–084 |
16.0–17.0 |
1.0–16.0 |
3.3–11.5 |
0.20–1.3 |
0.10–1.10 |
0.02–0.20 |
210–560 |
1 year |
10.1–13.0 |
3.9–5.1 |
0.30–0.38 |
070–082 |
16.0–16.0 |
1.0–18.0 |
3.4–10.5 |
0.20–0.9 |
0.05–0.90 |
0.02–0.13 |
200–500 |
2–6 years |
11.0–13.8 |
3.9–5.0 |
0.32–0.40 |
072–087 |
16.0–17.0 |
1.5–18.5 |
1.8–18.4 |
0.15–1.3 |
0.05–1.10 |
0.02–0.12 |
210–490 |
6–12 years |
11.1–14.7 |
3.9–5.2 |
0.32–0.43 |
076–090 |
14.5–14.5 |
1.5–18.0 |
1.5–15.0 |
0.15–1.3 |
0.05–1.00 |
0.02–0.12 |
170–450 |
12–18 years |
|
|
|
|
|
|
|
|
|
|
|
Female |
12.1–15.1 |
4.1–5.1 |
0.35–0.44 |
077–094 |
14.5–13.0 |
1.5–16.0 |
1.5–14.5 |
0.15–1.3 |
0.05–0.80 |
0.02–0.12 |
180–430 |
Male |
12.1–16.6 |
4.2–5.6 |
0.35–0.49 |
077–092 |
04.5–13.0 |
1.5–16.0 |
1.5–14.5 |
0.15–1.3 |
0.05–0.80 |
0.02–0.12 |
180–430 |
|
|
|
|
|
|
|
|
|
|
|
|
Compiled from various sources. Red cell values at birth derived from skin puncture blood; most other data from venous blood.
Reproduced with permission from Elsevier Science, from Hinchliffe RF: Reference values; in Lilleyman J, Hann I, Blanchette V (eds): Pediatric Hematology, ed 2. London, Churchill Livingstone, 1999, p 2.






|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
V |
Vaccine antigens 44 |
|
W |
Weight loss 46 |
|||
|
|
|
Vaginal bleeding 80 |
|
|
Wheezing 46, 76 |
||
|
|
|
Varicella 38, 52 |
|
|
Wilms tumor 78 |
||
|
|
|
Venom 68 |
|
|
Wiskott-Aldrich syndrome 44, 54, 56, 60 |
||
112 |
|
|
Viral illness 4, 78 |
|
|
|
|
|
|
|
Viral infection 50, 102 |
|
|
|
|
||
|
|
|
|
|
|
|
||
|
|
|
Virilization 78, 80 |
|
|
|
|
|
|
|
|
Viscera larva migrans 40 |
|
|
|||
|
|
|
Visual pathway tumor 90 |
|
|
|||
|
|
|
Vitamin B12 deficiency |
10, 12, 22, 42 |
|
|
|
Vitamin E deficiency 62
von Willebrand disease 60, 66 variant 52

Abbreviations
|
Ab |
Antibody |
CVL |
Central venous line |
GU |
Genitourinary |
|
ACD |
Acid citrate dextrose |
CXR |
Chest X-ray |
GVHD |
Graft-verses-host disease |
|
ACE |
Angiotensin converting enzyme |
DBA |
Diamond Blackfan anemia |
H&E |
Hematoxylin and eosin stain |
|
ACL |
Anticardiolipin antibody |
DCT |
Direct Coombs test or direct |
Hb |
Hemoglobin |
|
ACS |
Acute chest syndrome |
|
antiglobulin test |
HbA |
Hemoglobin A – adult hemoglobin |
|
AFP |
Alpha fetoprotein |
DDAVP |
1-deamino-8-D-arginine |
HbA2 |
Hemoglobin A2 |
|
Ag |
Antigen |
|
vasopressin |
HbF |
Hemoglobin F – fetal hemoglobin |
|
AIHA |
Autoimmune hemolytic anemia |
DIC |
Disseminated intravascular |
HbH |
Hemoglobin H |
|
ALL |
Acute lymphoblastic leukemia |
|
coagulation |
HBL |
Hepatoblastoma |
|
AML |
Acute myeloblastic leukemia |
DVT |
Deep vein thrombosis |
HbS |
Hemoglobin S - sickle hemoglobin |
|
ANA |
Antinuclear antibody |
Dx |
Diagnosis |
HbS +T |
Sickle + thalassemia |
|
ANC |
Absolute neutrophil count |
EBV |
Epstein-Barr virus |
HbS 0T |
Sickle 0 thalassemia |
|
APCR |
Activated protein C resistance |
ECG |
Electrocardiogram |
HbS T |
Sickle thalassemia |
|
APLA |
Antiphospholipid antibody |
ELISA |
Enzyme-linked immunoabsorbent |
HbSC |
Hemoglobin S-C disease |
|
ARDS |
Adult respiratory distress |
|
assay |
HbSS |
Homozygous sickle cell anemia |
|
|
syndrome |
EM |
Electron microscopy |
HCG |
Human chorionic gonadotrophin |
|
ASO |
Anti-streptolysin O |
Epo |
Erythropoietin |
HCT |
Hematocrit |
|
ASSC |
Acute splenic sequestration crisis |
ESR |
Erythrocyte sedimentation rate |
HE |
Hereditary elliptocytosis |
|
AT |
Antithrombin |
FFP |
Fresh frozen plasma |
HELLP |
Syndrome of hemolysis, elevated |
|
BCNU |
Carmustine |
FII |
Factor II (prothrombin) |
|
liver enzymes, low platelets |
|
BM |
Bone marrow |
FISH |
Fluorescence in situ hybridization |
HLA |
Human leucocyte antigen |
|
BMA |
Bone marrow aspirate |
FIX |
Factor IX |
HPFH |
Hereditary persistence of fetal |
|
BMB |
Bone marrow biopsy |
fl |
Femtoliter |
|
hemoglobin |
|
BMT |
Bone marrow transplant |
FSH |
Follicle stimulating hormone |
HUS |
Hemolytic uremic syndrome |
|
BP |
Blood pressure |
FSP |
Fibrin split products |
HVA |
Homovanillic acid |
|
BT |
Brain tumor |
FV |
Factor V |
Hx |
History |
|
BU |
Bethesda units |
FVII |
Factor VII |
ICH |
Intracerebral hemorrhage |
|
BUN |
Blood urea nitrogen |
FVIII:C |
Factor VIII coagulant activity |
IDA |
Iron deficiency anemia |
|
CBC |
Complete blood count |
FX |
Factor X |
IGF-1 |
Insulin growth factor-1 |
|
CD |
Cluster of differentiation (in flow |
FXI |
Factor XI |
IL |
Interleukin |
|
|
cytometry) |
FXII |
Factor XII |
ITI |
Immune tolerance induction |
|
CGD |
Chronic granulomatous disease |
FXIII |
Factor XIII |
ITP |
Immune thrombocytopenic |
|
CHF |
Congestive heart failure |
G-CSF |
Granulocyte colony stimulating |
|
purpura |
113 |
|
|||||
CML |
Chronic myelogenous leukemia |
|
factor |
IUGR |
Intrauterine growth retardation |
|
|
CMV |
Cytomegalovirus |
G6PD |
Glucose 6-phosphate |
IVIg |
Intravenous immunoglobulin |
|
CNS |
Central nervous system |
|
dehydrogenase |
JRA |
Juvenile rheumatoid arthritis |
|
CPDA-1 Citrate-phosphate-dextrose- |
GCT |
Germ cell tumor |
LAP |
Leukocyte alkaline phosphatase |
|
|
|
adenine |
GI |
gastrointestinal |
LCH |
Langerhans cell histiocytosis |
|
CSF |
Cerebrospinal fluid |
GM-CSF |
Granulocyte-macrophage colony |
LDH |
Lactate dehydrogenase |
|
CT |
Computerized tomography |
|
stimulating factor |
LFTs |
Liver function tests |
|
CVA |
Cerebrovascular accident |
GPI |
Glycosyl-phosphatidylinositol |
LH |
Luteinizing hormone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LM |
Light microscopy |
RCM |
Red cell mass |
|
|
|
|
Diagnoses in bolded text represent very |
|
|
||||
|
LMWH |
Low molecular weight heparin |
RDW |
Red cell distribution width |
|
|
|
|
LP |
Lumbar puncture |
RES |
Reticuloendothelial system |
common etiologies of that problem. |
|
|
|
MAHA |
Microangiopathic hemolytic |
RETIC |
Reticulocyte count |
Diagnoses in italicized text represent |
|
|
114 |
|
anemia |
rFVIIa |
Recombinant activated factor VII |
|
|
|
|
rare etiologies of that problem. |
|
|
||||
MCHC |
Mean corpuscular hemoglobin |
RIA |
Radioimmunoassay |
|
|
||
|
|
|
|
||||
|
|
concentration |
RMS |
Rhabdomyosarcoma |
|
|
|
|
MCV |
Mean corpuscular volume |
RT |
Radiotherapy |
|
|
|
|
MDS |
Myelodysplastic syndrome |
RT-PCR |
Reverse transcriptase |
|
|
|
|
MetHb |
Methemoglobin |
|
polymerase chain reaction |
|
|
|
|
MOPP |
Mechloramine, vincristine, pred- |
RUQ |
Right upper quadrant |
|
|
|
|
|
nisone, procarbazine |
Rx |
Treatment |
|
|
|
|
MPS |
Myeloproliferative syndrome |
SCD |
Sickle cell disease |
|
|
|
|
MPV |
Mean platelet volume |
SI |
Serum iron |
|
|
|
|
MRA |
Magnetic resonance angiography |
SLE |
Systemic lupus erythematosus |
|
|
|
|
MRI |
Magnetic resonance imaging |
SMEAR |
Blood smear |
|
|
|
|
NAIT |
Neonatal alloimmune thrombo- |
SVC |
Superior vena cava |
|
|
|
|
|
cytopenia |
TAR |
Thrombocytopenia-absent radii |
|
|
|
|
NBL |
Neuroblastoma |
|
syndrome |
|
|
|
|
NBT |
Nitroblue tetrazolium |
TEC |
Transient erythroblastopenia of |
|
|
|
|
NEC |
Necrotizing enterocolitis |
|
childhood |
|
|
|
|
NF1 |
Neurofibromatosis type 1 |
TIBC |
Total iron binding capacity |
|
|
|
|
NHL |
Non-Hodgkin lymphoma |
TNF |
Tissue necrosis factor |
|
|
|
|
Nl |
Normal |
TP |
Thrombocytopenia |
|
|
|
|
NRBC |
Nucleated erythrocytes |
TPA |
Tissue plasminogen activator |
|
|
|
|
NRSTS |
Non-rhabdomyosaroma soft |
TS |
Transferrin saturation |
|
|
|
|
|
tissue sarcoma |
TSH |
Thyroid stimulating hormone |
|
|
|
|
NSAID |
Nonsteroidal antiinflammatory |
TT |
Thrombin time |
|
|
|
|
|
drugs |
TTP |
Thrombotic thrombocytopenic |
|
|
|
|
O+P |
Stool sample for ova and |
|
purpura |
|
|
|
|
|
parasites |
U/A |
Urine analysis |
|
|
|
|
PCC |
Prothrombin complex |
UA |
Uric acid |
|
|
|
|
|
concentrates |
UAC |
Umbilical arterial catheter |
|
|
|
|
PCR |
Polymerase chain reaction |
US |
Ultrasound |
|
|
|
|
PE |
Pulmonary embolism |
V/Q |
Ventilation/perfusion |
|
|
|
|
PET |
Positron emission tomography |
VMA |
Vanillylmandelic acid |
|
|
|
|
PEx |
Physical examination |
VWD |
von Willebrand disease |
|
|
|
|
PFT |
Pulmonary function tests |
VWF |
von Willebrand factor |
|
|
|
|
PK |
Pyruvate kinase |
VWF:RCo von Willebrand factor activity |
|
|
|
|
|
PMN |
Polymorphonuclear neutrophil |
|
(ristocetin co-factor activity) |
|
|
|
|
PNET |
Primitive neuroectodermal tumor |
VWFAg |
von Willebrand antigen activity |
|
|
|
|
PNH |
Paroxysmal nocturnal hemo- |
W/U |
Workup |
|
|
|
|
|
globinuria |
WAS |
Wiskott-Aldrich syndrome |
|
|
|
|
PRBC |
Packed red blood cells |
WBC |
White blood cell |
|
|
|
|
PT |
Prothrombin time |
XR |
X-ray |
|
|
|
|
PTT |
Partial thromboplastin time |
|
|
|
|
|
|
R/O |
Rule out |
7 |
Decreased |
|
|
|
|
RBC |
Red blood cell |
& |
Increased |
|
|
|
|
|
|
|
|
|
|
|